Henry Withers of Roswell Park Cancer Institute, Department of Genetics gives an overview of his presentation, Characterization of an off-target RNAi genomic screen hit identifies GPRC6A as a novel suppressor of metastatic chemotaxis and invasiveness, which was presented at the American Association for Cancer Research (AACR) 2017 Annual Meeting in Washington, DC.